title: [Effectiveness of enap and oliphen combined treatment of chronic pulmonary hypertension].
authors.forename: M A
authors.initials: MA
authors.lastname: Shkol'nik
authors.forename: I V
authors.initials: IV
authors.lastname: Butorov
authors.forename: R F
authors.initials: RF
authors.lastname: Fuduleĭ
authors.forename: V I
authors.initials: VI
authors.lastname: Paraska
authors.forename: N I
authors.initials: NI
authors.lastname: Bodrug
mesh_terms: D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000975:Antioxidants / Q000627:therapeutic use*; D002908:Chronic Disease; D004359:Drug Therapy, Combination; D004656:Enalapril / Q000627:therapeutic use*; D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010647:Phenyl Ethers / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D000975:Antioxidants; D010647:Phenyl Ethers; C085806:olifen; D004656:Enalapril